Center for Innovative NeuroTech Advancement: Administrative Core
Official title: Center for Innovative NeuroTech Advancement (CINTA) - Administrative Core
Funded at Massachusetts General Hospital · NIH-11602007 · Data updated 2026-11-12
A national hub led by Massachusetts General Hospital to streamline leadership, policy, and coordination across neurotechnology initiatives to help patients faster access better brain-technology tools.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Massachusetts General Hospital NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project start | September 30, 2022 |
| Project end | June 30, 2027 |
| Funding year | 2026 |
| Award (this year) | $1,536,867 |
| NIH project number | 3U54EB033650-05S5 |
| Project ID | NIH-11602007 on NIH RePORTER |
Who could benefit from this research
✓Could help
Patients with neurological conditions who may benefit from future neurotechnology innovations could indirectly gain access as the program translates discoveries into clinical tools.
✕Less likely to help
This administrative grant does not directly enroll patients; it focuses on governance and coordination for future patient-focused projects.
What this research studies
This grant funds an Administrative Core that guides and speeds up how neurotech projects move from idea to patient care. It builds governance, policies, and real-time metrics to improve efficiency and impact, with input from a Steering Committee that includes patient advocates. The core coordinates multiple sub-centers and ensures alignment with NIH goals and clinical translations. It emphasizes patient-centered planning and collaboration with national leaders to bring innovations to the clinic.
Why it matters
Potential benefit: If successful, the hub could shorten the path from neurotechnology ideas to real-world patient therapies.
How similar studies have gone: Previous administrative cores in related centers have successfully accelerated translation and collaboration across programs.
Where this research is happening
-
Massachusetts General Hospital
Boston, United States Active
Researchers
- Principal investigator: Schachter, Steven C. — Massachusetts General Hospital
- Study coordinator: Schachter, Steven C.
Related research
Other NIH-funded projects on the same topics.
-
Global TravEpiNet: Pregnant Travelers Health and Disease Prevention Network
This grant supports a national network to improve health and prevent infections among international travelers, with a special focus on pregnant travelers.
-
Soluble ST2 and the course of lung injury in ARDS
A doctor-scientist at a top hospital is studying how a molecule called soluble ST2 may influence how lung injury starts and heals in patients with ARDS and related conditions.
-
Role of airway macrophages in lung health and allergic disease
A doctor-scientist at a major hospital wants to study how immune cells in the airways develop and influence asthma and other airway diseases.
-
Global TravEpiNet: Understanding and Protecting US Travelers, including Pregnant Travelers
A large U.S. network studies international travelers, including pregnant travelers, to understand illness risks and reduce the spread of infections.
-
Gait speed from wearable sensors to guide ALS trials
A patient-friendly look at using wearable sensors to measure how fast people with ALS walk, to help run better ALS trials.
-
Determinants of Post-Stroke Cognitive Outcomes and Vascular Effects on Recovery
A large, multi-site effort aims to understand why some stroke survivors develop long-term cognitive problems and dementia, and how vascular health and pre-existing brain changes influence recovery.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.